List of Clinical Studies

A Randomized, Controlled, Open-Label, Rater-Blinded, Phase 3b Study of the Efficacy, Safety, and Tolerability of 6-Week Extended Interval Dosing of Natalizumab (BG00002) in Subjects With Relapsing-Remitting Multiple Sclerosis Switching From Treatment With 4-Week Natalizumab Standard Interval Dosing (SID) in Relation to Continued SID Treatment
Read more.

Mary Ann Picone, MD

Randomized, multi-center, double-blinded, active-controlled study that is primarily designed to assess the Annualized Relapse Rate (ARR) and safety/tolerability of ublituximab/oral placebo (TG-1101; UTX) as compared to teriflunomide/IV placebo in subjects with Relapsing MS.
Read more.

Mary Ann Picone, MD

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study in Subjects With Relapsing Multiple Sclerosis to Evaluate the Efficacy and Safety of BIIB033 as an Add-On Therapy to Anti-Inflammatory Disease-Modifying Therapies
Read more.

Mary Ann Picone, MD

Effect of MD1003 in progressive multiple sclerosis: a randomized double blind placebo controlled study
Read more.

Mary Ann Picone, MD

An Open-Label Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Patients With Relapsing Remitting Multiple Sclerosis Who Have Had A Suboptimal Response To An Adequate Course Of Disease-Modifying Treatment
Read more.

Mary Ann Picone, MD

A long-term follow-up study for Multiple Sclerosis patients who have completed the alemtuzumab Extension Study (CAMMS03409)
Read more.

Mary Ann Picone, MD

A Phase Iii, Multicentre, Randomized, Parallel-Group, Double Blinded, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Adults With Primary Progressive Multiple Sclerosis
Read more.

Mary Ann Picone, MD

A Trial of Prednisone and Acetaminophen Versus Acetaminophen Alone in Minimizing Flu-like Symptoms From Pegylated Interferon Beta-1a
Read more.

Mary Ann Picone, MD

We are open.
We are clean.
We are ready.

Medical Care

Cancer Care

Specialty Services

Medical Care & Treatments

Patients & Visitors

For Patients

For Visitors

Directions & Parking

Amenities & Services

Community Health

About Holy Name Medical Center

Quick Links

Key Phone Numbers

Medical Center Operator

Physician Referral Service

Patient Information

Foundation (Donations)

Human Resources

Medical Staff Office

In This Section

For More Information:

List of Clinical Studies


Multiple Sclerosis

Study Name	Principal Investigator

A Randomized, Controlled, Open-Label, Rater-Blinded, Phase 3b Study of the Efficacy, Safety, and Tolerability of 6-Week Extended Interval Dosing of Natalizumab (BG00002) in Subjects With Relapsing-Remitting Multiple Sclerosis Switching From Treatment With 4-Week Natalizumab Standard Interval Dosing (SID) in Relation to Continued SID Treatment Read more.	Mary Ann Picone, MD

Randomized, multi-center, double-blinded, active-controlled study that is primarily designed to assess the Annualized Relapse Rate (ARR) and safety/tolerability of ublituximab/oral placebo (TG-1101; UTX) as compared to teriflunomide/IV placebo in subjects with Relapsing MS. Read more.	Mary Ann Picone, MD

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study in Subjects With Relapsing Multiple Sclerosis to Evaluate the Efficacy and Safety of BIIB033 as an Add-On Therapy to Anti-Inflammatory Disease-Modifying Therapies Read more.	Mary Ann Picone, MD

Effect of MD1003 in progressive multiple sclerosis: a randomized double blind placebo controlled study Read more.	Mary Ann Picone, MD

An Open-Label Study To Evaluate The Effectiveness And Safety Of Ocrelizumab In Patients With Relapsing Remitting Multiple Sclerosis Who Have Had A Suboptimal Response To An Adequate Course Of Disease-Modifying Treatment Read more.	Mary Ann Picone, MD

A long-term follow-up study for Multiple Sclerosis patients who have completed the alemtuzumab Extension Study (CAMMS03409) Read more.	Mary Ann Picone, MD

A Phase Iii, Multicentre, Randomized, Parallel-Group, Double Blinded, Placebo Controlled Study To Evaluate The Efficacy And Safety Of Ocrelizumab In Adults With Primary Progressive Multiple Sclerosis Read more.	Mary Ann Picone, MD

A Trial of Prednisone and Acetaminophen Versus Acetaminophen Alone in Minimizing Flu-like Symptoms From Pegylated Interferon Beta-1a Read more.	Mary Ann Picone, MD

We are open.We are clean.We are ready.

Medical Care

Cancer Care

Specialty Services

Medical Care & Treatments

Patients & Visitors

For Patients

For Visitors

Directions & Parking

Amenities & Services

Community Health

About Holy Name Medical Center

Quick Links

Key Phone Numbers

Medical Center Operator

Physician Referral Service

Patient Information

Foundation (Donations)

Human Resources

Medical Staff Office

List of Clinical Studies

In This Section

For More Information:

List of Clinical Studies

We are open.
We are clean.
We are ready.